309 related articles for article (PubMed ID: 21697068)
1. Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.
Di Cesare A; Fidanza R; Riitano A; Fargnoli MC; Peris K
Eur J Dermatol; 2011; 21(5):784-5. PubMed ID: 21697068
[No Abstract] [Full Text] [Related]
2. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
3. Mea culpa.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
[No Abstract] [Full Text] [Related]
4. [Inflammatory diseases of the intestines].
Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
[TBL] [Abstract][Full Text] [Related]
5. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
Yamamoto T; Umegae S; Matsumoto K
Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
[TBL] [Abstract][Full Text] [Related]
6. [Interstitial nephritis associated with mesalazine therapy].
Vuotila M; Ikäheimo R; Pietiläinen T
Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
[No Abstract] [Full Text] [Related]
7. [Pentasa (mesalazine) and pregnancy].
Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
[TBL] [Abstract][Full Text] [Related]
8. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
9. Trends in inflammatory bowel disease therapy.
Thomson AB; Williams CN
Can J Gastroenterol; 1999 Nov; 13(9):775-6. PubMed ID: 10633831
[No Abstract] [Full Text] [Related]
10. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
11. [Mesalazine-induced acute pericarditis].
Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
[No Abstract] [Full Text] [Related]
12. [Mesalazine].
Engelhardt K; Mohr K
Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
[No Abstract] [Full Text] [Related]
13. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease.
Podolsky DK
N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
[No Abstract] [Full Text] [Related]
15. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
16. [Drug therapy of inflammatory bowel diseases].
Silvennoinen J; Niemelä S
Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
[No Abstract] [Full Text] [Related]
17. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
18. Look out for toxic effects of mesalamines!
Goldstein F
J Clin Gastroenterol; 2001 Feb; 32(2):98. PubMed ID: 11205663
[No Abstract] [Full Text] [Related]
19. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
Bhidayasiri R; Katz JA; Sokos DR
Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
[No Abstract] [Full Text] [Related]
20. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE
Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
